Navigation Links
Genesis Biopharma Director William H. Andrews, Ph.D., Profiled in Popular Science Feature Story
Date:7/15/2011

LOS ANGELES, July 15, 2011 /PRNewswire/ -- The current issue of Popular Science magazine includes a feature story profiling William H. Andrews, a member of the Genesis Biopharma, Inc. (OTC/BB: GNBP) Board of Directors, and his work on the anti-aging properties of the human telomerase gene.

The entire 11-page story, titled "The Man Who Would Stop Time" by Joseph Hooper, can be found at www.popsci.com

About Genesis Biopharma, Inc.

Genesis Biopharma, Inc. is a development-stage biotechnology company engaged in the development of targeted cancer therapies. For more information about the company, visit www.genesis-biopharma.com.


'/>"/>
SOURCE Genesis Biopharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Laszlo Radvanyi, Ph.D. Joins Genesis Biopharma Scientific and Medical Advisory Board
2. Genesis Biopharma Conference Call and Webcast Reminder
3. Genesis Biosciences Receives Pulire Innovation Award for e card Sanitary Bin Treatment Product
4. Patrick Hwu, M.D., and Mario Sznol, M.D., Join Genesis Biopharmas Scientific and Medical Advisory Board
5. Governor Gray Davis Joins Genesis Biopharma as Chairman of Corporate Advisory Board
6. ThermoGenesis Announces China Customer Implements Cord Blood Products
7. Tissue Genesis Begins FDA-Approved Clinical Trial
8. CryoLife Amends Tender Offer Related to its Proposed Acquisition of Cardiogenesis Corporation
9. Organogenesis, Life Sciences Center Break Ground on Worlds Largest Automated Living Cell Manufacturing Plant
10. Announcing ValGenesis On-Demand SaaS Solution
11. Reportlinker Adds Global Angiongenesis Inhibitors and Stimulators Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... 17, 2017 The Global Implantable Biomaterials ... of around 7.5% over the next decade to ... the prominent trends that the market is witnessing ... & graft transplant surgeries and medical implants and ... is categorized into immunomodulatory biomaterials, natural, polymers, hydrogels ...
(Date:1/17/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today ... earnings conference call will be broadcast live over the ... Eastern Time.  A news release detailing the quarterly and ... Eastern Time the morning of the conference call. ... Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com . ...
(Date:1/17/2017)... Jan. 17, 2017 Research and Markets ... "Molecular Diagnostics - Technologies, Markets and Companies" to their ... ... increased remarkably during the past few years. More than 1,000 ... diagnostics and 342 of these are profiled in the report ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... annual meeting of the North American Spine Society (NASS)1 demonstrate high fusion ... majority of cases, when PEEK-OPTIMA™ HA Enhanced is used for interbody-fusion devices. ...
Breaking Biology Technology:
(Date:1/6/2017)... Calif. , Jan. 6, 2017  Privately-held ... safety studies in healthy volunteers of a novel ... to treat acute pancreatitis. Acute ... typically a mild disorder, but can be very ... failure and sepsis, where extended hospital stays, time ...
(Date:1/4/2017)... of attendees at this year,s International Consumer Electronics Show (CES), A&D ... and services, will be featuring its new line of ULTRA CONNECT ... CES Exhibit Suite , the new upper arm and wrist smart blood ... product platform.  Continue Reading ... ...
(Date:12/22/2016)... , Dec. 20, 2016  As part of its longstanding ... leading personal genetics company, recently released its latest children,s book, ... The book focuses on the topics of inheritance and variation ... Standards (NGSS) taught in elementary school classrooms in the US. ... series by illustrator Ariana Killoran , whose previous book ...
Breaking Biology News(10 mins):